![ROI’s Into the Corner Office Podcast: Powerhouse Middle Market CEOs Telling it Real—Unexpected Caree...](https://fastfs1.podbean.com/themes/FrontRow/images/detail_banner_v1.jpg)
![ROI’s Into the Corner Office Podcast: Powerhouse Middle Market CEOs Telling it Real—Unexpected Caree...](https://pbcdn1.podbean.com/imglogo/image-logo/13125971/Podcast_Cover_No_Guest_v3_2000_x_2000_px_1_1__y5n8qg.png)
35.3K
Downloads
354
Episodes
The road to the middle market CEO corner office is paved with mile markers that guide in surprising, unpredictable, and some might even say “mysterious” ways! But how do you get such a widely coveted position? This is the question often heard during decades of ROI’s executive search interviews, conducted with top-level executives. ROI’s Into the Corner Office podcast is a new inspiration and answer platform which premieres visionary tales of adventure with great endings and highlights, from powerhouse CEOs driving the formidable success of the U.S. economy’s middle market sector. The CEOs behind this impressive growth reveal insights which equipped them to lead their organizations. Showcasing dynamic leadership stories, Into the Corner Office dives into the heart of what informed and formed these CEOs. Guests share their backgrounds, talk about their early years, and explore what shaped them before they were known for their successes in growing, developing, and leading extraordinary mi...
Episodes
![Michael Castagna, CEO, MannKind Corporation](https://pbcdn1.podbean.com/imglogo/image-logo/13125971/Podcast_Cover_No_Guest_v3_2000_x_2000_px_1_1__y5n8qg_300x300.png)
Tuesday Aug 04, 2020
Michael Castagna, CEO, MannKind Corporation
Tuesday Aug 04, 2020
Tuesday Aug 04, 2020
Michael Castagna is our Chief Executive Officer and serves on the Board of Directors for MannKind Corporation. Dr. Castagna has over 20 years of experience in healthcare, pharmaceutical, biotech, and specialty pharmacy industries. He joins MannKind from Amgen, Inc., where he spent over three years as Vice President, Global Commercial Lead for a portfolio of nine biosimilar drugs, and Vice President, Global Lifecycle Management. Prior to Amgen, Dr. Castagna, was Executive Director of Bristol-Myers Squibb’s Immunology franchise, where he served as co-lead to relaunch Orencia IV and launch Orencia SC, both rheumatoid arthritis drugs. Before BMS, Dr. Castagna was with Sandoz (Novartis) as Vice President and Division Head for Biopharmaceuticals, North America, where he established the US Biologics Business Unit and relaunched its lead product, Omnitrope, a human growth hormone. Prior to Sandoz, he held a variety of positions with EMD (Merck), Serono, Pharmasset and DuPont Pharmaceuticals. He received his Bachelors of Science – Pharmacy degree from Philadelphia College of Pharmacy, his Doctor of Pharmacy from Massachusetts College of Pharmacy, and his MBA from the Wharton School of Business at the University of Pennsylvania.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.